We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRON
1376
CALL
Cronos Group
CRON
$1.15B
$10K ﹤0.01%
600
DIN icon
1377
Dine Brands
DIN
$450M
$10K ﹤0.01%
+100
New +$9.13K
EHC icon
1378
Encompass Health
EHC
$12.4B
$10K ﹤0.01%
+189
New +$9.17K
FAST icon
1379
PUT
Fastenal
FAST
$58.3B
$10K ﹤0.01%
+600
New +$9.89K
FRO icon
1380
PUT
Frontline
FRO
$8.81B
$10K ﹤0.01%
+1,300
New +$10.3K
GOOS
1381
Canada Goose Holdings
GOOS
$837M
$10K ﹤0.01%
250
HCI icon
1382
HCI Group
HCI
$2.31B
$10K ﹤0.01%
+252
New +$10.5K
HL icon
1383
Hecla Mining
HL
$10.7B
$10K ﹤0.01%
+5,794
New +$10.6K
INO icon
1384
Inovio Pharmaceuticals
INO
$69.6M
$10K ﹤0.01%
+288
New +$11.4K
MTC icon
1385
MMTec
MTC
$299M
$10K ﹤0.01%
+7
New +$3.03K
ORLY icon
1386
O'Reilly Automotive
ORLY
$76.2B
$10K ﹤0.01%
+390
New +$9.88K
RACE icon
1387
Ferrari
RACE
$71.6B
$10K ﹤0.01%
+64
New +$9.21K
RVTY icon
1388
Revvity
RVTY
$12.7B
$10K ﹤0.01%
99
-3,822
-97% -$356K
STRO icon
1389
Sutro Biopharma
STRO
$400M
$10K ﹤0.01%
+91
New +$10K
TRU icon
1390
TransUnion
TRU
$15.2B
$10K ﹤0.01%
+131
New +$8.96K
VRSK icon
1391
Verisk Analytics
VRSK
$24.7B
$10K ﹤0.01%
67
-308
-82% -$43.4K
WEX icon
1392
WEX
WEX
$6.46B
$10K ﹤0.01%
+46
New +$9.26K
YMAB
1393
DELISTED
Y-mAbs Therapeutics
YMAB
$10K ﹤0.01%
+458
New +$10.5K
ONIT
1394
Onity Group
ONIT
$311M
$10K ﹤0.01%
+323
New +$8.62K
NBIS
1395
Nebius Group N.V.
NBIS
$48.2B
$10K ﹤0.01%
250
-4,628
-95% -$172K
CATC
1396
DELISTED
CAMBRIDGE BANCORP
CATC
$10K ﹤0.01%
+126
New +$10.4K
PRTK
1397
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10K ﹤0.01%
2,497
-93
-4% -$442
CNCE
1398
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$10K ﹤0.01%
+804
New +$8.65K
PCSB
1399
DELISTED
PCSB Financial Corporation
PCSB
$10K ﹤0.01%
+498
New +$9.65K
FTSV
1400
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$10K ﹤0.01%
+950
New +$13.9K

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.